Joel Greenblatt's ANAB Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 13,972 shares of AnaptysBio, Inc. (ANAB) worth $774,887, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in ANAB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's AnaptysBio (ANAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly AnaptysBio (ANAB) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +13,972 | New Buy | 13,972 | $55.46 |
Joel Greenblatt's AnaptysBio Investment FAQs
Joel Greenblatt first purchased AnaptysBio, Inc. (ANAB) in Q1 2026, acquiring 13,972 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held AnaptysBio, Inc. (ANAB) for 1 quarters since Q1 2026.
Joel Greenblatt's largest addition to AnaptysBio, Inc. (ANAB) was in Q1 2026, adding 13,972 shares worth $774,887.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 13,972 shares of AnaptysBio, Inc. (ANAB), valued at approximately $774,887.
As of the Q1 2026 filing, AnaptysBio, Inc. (ANAB) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in AnaptysBio, Inc. (ANAB) was 13,972 shares, as reported at the end of Q1 2026.